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Prevalence of tobacco, cocaine and alcohol use amongst patients attending for 
Methadone-Maintenance Therapy in a rural setting 
 
 
Background: Patients receiving methadone-maintenance therapy appear more likely 
to have other substance-use disorders than do people in the general population and 
often fail to receive treatment for these conditions. Coexisting substance-use disorders 
are associated with poor health outcomes amongst current or former heroin users. The 
aim of this study was to establish the prevalence of the use of tobacco, cocaine and 
alcohol amongst patients attending for community-based methadone-maintenance 
therapy. Methods: Cross-sectional survey of patients prescribed methadone as to treat 
opiate dependence. Results: Prevalence of tobacco, cocaine and alcohol use in the 
sample were 91.18%, 11.18% and 42.01%, respectively. Most respondents were 
found to be dependent upon tobacco. In contrast, most patients were found to have no 
dependence upon alcohol. In total, 145 patients (85.80%) had Alcohol Use Disorders 
Identification Test PC (AUDIT PC) scores below 5, indicating lower risk drinking, 
while the remaining 24 (14.20%) had AUDIT scores of 5 or above, indicating higher 
risk drinking. Conclusions: There are higher rates of self-reported tobacco, cocaine 
and alcohol use disorders amongst methadone-maintained individuals than those 
reported in individuals from the general population. The findings illustrate the 
importance of identifying coexisting tobacco, cocaine and alcohol use disorders in 
methadone-maintained patients, since these issues can significantly impair patients’ 
quality of life and affect treatment outcomes. 
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Prevalence of tobacco, cocaine and alcohol use amongst patients attending for 
Methadone-Maintenance Therapy in a rural setting 
 
Background 
While opiate substitute treatment has proven to be effective in decreasing substance 
misuse, clients may not stop all drug use immediately after entering treatment; rather, 
eradicating all illicit drug and alcohol misuse may take months or years (Department 
of Health, 2007). Despite this, there are studies corroborating a decrease in the use of 
heroin and other illicit substances amongst individuals receiving methadone-
maintenance treatment (Ward, Hall, & Mattick, 1999). The coexisting use of 
substances such as cocaine can affect the programme’s effectiveness, as has been 
demonstrated in observational studies (Ward et al., 1999). It is generally agreed that 
the stabilisation of one pattern of drug misuse may still be associated with the 
ongoing problematic use of other substances, and this presents a challenge both to 
staff and for programme delivery. The substances most frequently misused are 
tobacco and alcohol (Farrell et al., 1994). 
 
A variety of factors that play a role in the increased rate of tobacco use amongst 
methadone-maintained patients have been identified: While some smoke to counteract 
methadone taste and withdrawal, others do so as a part of the drug use ritual and to 
manage drug-induced behaviours. It has been suggested that methadone and smoking 
use may be a reciprocally enhanced behaviour, since some tobacco users may use 
methadone to counteract the side effects of smoking, and in some cases where there is 
sore throat associated with heavy tobacco use, smokers may use methadone in order 
to continue smoking (Mccool & Richter, 2003). 
  
 
Individuals receiving methadone treatment for opiate dependence drink more alcohol 
than similar age groups in the general population, but their alcohol intake is not higher 
than opioid-dependent persons who are not receiving opiate replacement therapy 
(Hunt et al., 1986). While some studies have identified heavy alcohol consumption in 
up to half of all patients in methadone maintenance (Kreek, 1990), others have  
reported that approximately 33% of methadone-maintained patients have current 
drinking problems and one-sixth have a history of a drinking problem (Senbanjo, 
Wolff, & Marshall, 2007). This trend is cause for concern, since greater psychosocial 
pathology, elevated rates of treatment failure and increased criminal activity are 
related with alcohol misuse (Best et al., 1998). Therefore, estimating the prevalence 
for these coexisting conditions is a fundamental procedure, since overlooking such 
needs may produce an adverse impact on overall treatment and outcome. The latest 
estimated prevalence of alcohol use among adults in the general population of Great 
Britain, according to the 2009 General Lifestyle Survey, is 85% of adults in the 
general population (Robinson & Harris, 2009). 
 
While the prevalence of cocaine use in the general population between 16 and 59 
years of age in the UK is 2.2% (Home Office, 2011), the prevalence of current 
cocaine use amongst methadone-maintained individuals has been found to be 
significantly higher than prevalence of cocaine use in the general population. A 
survey by Hasin, Grant, Endicott and Harford  (1988) found a prevalence of 92% of 
cocaine use in a group of heroin users not engaged in methadone treatment (Hasin, 
Grant, Endicott, & Harford, 1988). Correspondingly, elevated rates of illicit cocaine 
use have been detected in heroin-dependent individuals receiving methadone-
  
maintenance therapy during the continuation of treatment (Leri, Stewart, Tremblay, & 
Bruneau, 2004). A study by Hartel et al. (1995) found a prevalence of cocaine use of 
51.7% amongst patients receiving methadone-maintenance treatment (Hartel et al., 
1995). A survey by Magura, Kang, Nwakeze and Demsky (1998) found that 73% of 
1,038 patients receiving methadone therapy tested positive for cocaine on urinalysis 
(Magura, Kang, Nwakeze, & Demsky, 1998). Another study reported that 50% of 
methadone-maintained patients were positive for cocaine (Grella, Anglin, & 
Wugalter, 1997), and Black et al (1987) confirmed that in a group of methadone-
maintained individuals, the results were positive in 63% of the samples screened for 
the cocaine metabolite benzoylecgonine (Black, Dolan, Penk, Robinowitz, & Deford, 
1987). As methadone is not a pharmacological therapy for cocaine, a direct 
relationship between methadone dose and cocaine use is not to be expected. It has 
been reported that cocaine use accelerates methadone elimination (Moolchan, 
Umbricht, & Epstein, 2001); therefore, methadone-maintained patients who also use 
cocaine may need increased amounts of methadone to reach therapeutic levels as an 
opiate substitute treatment. 
 
While methadone-maintenance treatment may produce a positive impact on illicit 
drug- related outcomes, research indicates that general lifestyle and health problems 
may continue or even increase (Best et al., 1998). As coexisting substance-use 
disorders are especially associated with general lifestyle and health problems amongst 
current or former heroin users (Patton, Smythe, Kelsall, & Selemo, 2007), estimating 
the prevalence of patients with these coexisting substance-use disorders is an essential 
procedure, since overlooking these needs can have a negative influence on overall 
treatment and outcome. To that end, the present study investigates the prevalence of 
  
the use of tobacco, cocaine and alcohol amongst adult substance misusers attending 
for community-based methadone-maintenance therapy in a rural setting.  
 
 
Methods 
This is a cross-sectional survey of drug users aged over 18 years presenting to 
specialist drug services in East Kent. These services were provided by a voluntary 
agency, KCA (Kent Counselling for Addictions) UK. East Kent is mainly a rural area, 
with a population of about 624,000 and at the time of the study about 800 patients 
were in treatment for opiate dependence. The majority of these methadone-maintained 
patients (an estimated 80%) are supervised daily by a community pharmacist. The 
remaining patients are allowed partial take-home doses of methadone with supervised 
consumption at least once weekly.  
 
All clients attending KCA services who met ICD-10 criteria for opiate dependence, 
who were stabilised on methadone treatment for at least two months and who were 
not under the effects of drugs or alcohol and were not displaying withdrawal 
symptoms were eligible to participate in the survey. Patients who met these inclusion 
criteria were approached by their designated community drug worker and asked to 
participate in the study during key working sessions and after clinic appointments. 
They were given an information sheet with detailed information about the study; once 
they indicated that this information was clear to them, they completed the 
questionnaire. The participants did not receive payment as an incentive for taking part 
in the study. The entire procedure lasted about 30 minutes for each participant. Ethical 
approval for the study was given by the local NHS REC. 
  
 
 
 
The study questionnaire consisted of socio-demographic data and a battery of brief, 
reliable and validated instruments described below. The main variables measured 
were alcohol use, harmful use and dependence, tobacco use and dependence, and 
cocaine use and dependence. The following questionnaires were used: The severity of 
dependence scales (SDS) (Gossop et al., 1995), The Severity of Alcohol Dependence 
Questionnaire (SADQ-C) – Community version (Stockwell, Sitharthan, Mcgrath, & 
Lang, 1994; Stockwell, Murphy, & Hodgson, 1983), and The Alcohol Use Disorders 
Identification Test (AUDIT) – Primary Care version (Gomez, Conde, Santana, & 
Jorrin, 2005; Saunders, Aasland, Babor, Delafuente, & Grant, 1993). 
 
Dependence upon tobacco and cocaine was assessed using the SDS, and the SADQ-C 
scale was used for alcohol dependence. For the SDS, scores of 4+ were considered 
indicative of dependence. For the SADQ-C, scores less than 4 indicated no 
dependence, scores between 4 and 19 indicated mild dependence, scores between 20 
and 30 indicated moderate dependence, scores between 31 and 44 indicated severe 
dependence, and scores of 45 or above indicated very severe dependence. Alcohol use 
and dependency was also measured by the AUDIT PC questionnaire. AUDIT PC 
scores of five or above were used to indicate hazardous drinking.  
 
 
Results 
 
  
The recruitment of participants was carried out over a four month period. A total of 
170 patients were invited to take part in the study. No patients declined, giving a 
participation rate of 100%. Most respondents were male (61.76%) and white British 
(88.82%). About a quarter of all respondents (23.5%) indicated that they were 
engaged in some form of paid employment, with rest on sickness (46.5%) or 
unemployment benefits (23.0%). 
 
The SDS and AUDIT PC were used to estimate the total number and percentage of 
respondents who were current users of tobacco, cocaine and alcohol. The results 
indicated that the vast majority of respondents (91.2%) were current tobacco users, 
with 11.2% using cocaine and 42% alcohol. 
 
The majority of patients who used tobacco were found to be dependent upon it 
(91.6% of all tobacco smokers; 83.5% of sample). A small number (n=17, 89.5% of 
all cocaine users; 10.00% of sample) were found to be dependent upon cocaine. In 
total, four patients (5.6% of all alcohol users; 2.37% of sample) were moderately 
dependent upon alcohol, with six respondents indicating severe dependence (8.5% of 
all alcohol users; 3.55% of sample). Twenty-four respondents (33.8% of all alcohol 
users; 14.20% of sample) indicated hazardous or higher risk drinking. 
 
 
Discussion  
The present study assessed the prevalence of coexisting substance disorders in 
methadone-maintained individuals. It was found that the estimated prevalence of 
tobacco, cocaine and alcohol use in the sample were 91.2%, 11.2% and 42.0%, 
  
respectively. Such rates are comparable with previously published data: Chun et al 
(2009) identified a tobacco prevalence of 95% (Chun, Haug, Guydish, Sorensen, & 
Delucchi, 2009). Best et al. (1998) reported alcohol prevalence rates between 20% 
and 50% in a group of individuals receiving methadone-maintenance treatment (Best 
et al., 1998). The prevalence of cocaine use found in the present study in methadone-
maintained individuals was 11.11%, and this is notably lower than the prevalence 
reported in previous studies (Hartel et al., 1995; Magura et al., 1998; Grella et al., 
1997), which indicated a prevalence of between 50% and 73%. A plausible 
explanation for this may be that adults living in mainly rural communities such as 
East Kent are expected to experience less use of Class A drugs than those living in 
urban areas. This explanation may be reinforced by the findings of the British Crime 
Survey, which found that 9.3% of adults living in urban areas used illicit drugs, 
whereas the rate of illicit drug use of those living in rural areas was 7.0% (Home 
Office, 2011). 
 
The prevalence of tobacco use identified in this study, 91.8%, supports the claim that 
the prevalence of smoking among patients receiving methadone-maintenance 
treatment can be three to four times that of the general population (Sobell, Sobell, & 
Agrawal, 2002). This was the finding of the present study, since the prevalence of 
smoking tobacco amongst individuals in the general population in Great Britain is 
21% or higher after adjustments for non-detection through misreports of tobacco 
smoking. The tobacco prevalence shown in the present study is also consistent with 
published data showing that the smoking rate for people in methadone treatment is 
over 90% (Shadel et al., 2005) and supporting the statement that amongst all kinds of 
drug treatments, higher tobacco prevalence has been described for methadone-
  
maintained individuals (Clemmey, Brooner, Chutuape, Kidorf, & Stitzer, 1997). In 
the present study, the majority of respondents (83.53%) were found to be dependent 
upon tobacco. 
 
Since the vast majority of methadone-maintained individuals smoke, it is expected  
that they will experience high levels tobacco-related morbidity and mortality (Richter 
& Ahluwalia, 2000). Nevertheless, drug treatment programmes normally do not 
include smoking cessation activities as these are considered a low treatment priority 
due to misconceptions that offering such interventions are ineffective upon this 
population, and could reduce attendances to services (Chun et al., 2009). Previous 
research has found that only one out of three services provide tobacco counselling, 
and just one out of ten offer nicotine replacement therapy (Richter, Choi, Mccool, 
Harris, & Ahluwalia, 2004). 
  
It has been stated that the continuous use of tobacco leads to a dependence 
comparable to those resulting from the use of other drugs, with similar factors that 
influence initiation, abstinence and relapse (Henningfield, Clayton, & Pollin, 1990). A 
variety of factors that play a role in the increased rate of tobacco use amongst 
methadone-maintained patients have been identified. While some smoke to counteract 
methadone taste and withdrawal, others do so as a part of the drug use ritual and to 
manage drug-induced behaviours. It has been suggested that methadone and smoking 
use may be a reciprocally enhanced behaviour, since some tobacco users may use 
methadone to counteract the side effects of smoking, and in some cases where there is 
sore throat associated with heavy tobacco use, smokers may use methadone in order 
to continue smoking (Mccool & Richter, 2003) . 
  
 
It has been reported that there is an association between methadone and nicotine in 
methadone-maintained participants who consumed more methadone; one study 
observed the effects of nicotine abstinence, ad libitum smoking and three different 
concentrations of nicotine gums on methadone self-administration. The individuals 
used more methadone in ad libitum smoking conditions than they did when following 
the abstinence condition (Spiga, Schmitz, & Day, 1998). Although the results of this 
survey suggest that there is a relationship between nicotine and methadone usage, 
causality remains uncertain. 
 
The elevated degree of their coexistence implies that opiates and nicotine not only 
share related environmental and societal risk factors, but also physiological 
interactions that add to the beginning and continuation of dependence. Methadone and 
nicotine produce positive mood changes after their consumption; they also produce 
similar physiological results and symptoms, for example, certain mood disturbances, 
anxiety and sleeping problems (Hughes, Higgins, & Bickel, 1994). Nicotine and 
methadone seem to act on neurons that use dopamine as a neurotransmitter, and these 
cells are thought to play a role in the development of dependence (Gardier, 1997). 
Opioids and nicotine alter biochemical processes and therefore human behaviours. 
Opiate and tobacco dependence could be consequences of opiate and tobacco 
biochemical actions as well as the societal background in which illicit drug misuse 
occurs. 
 
Methadone and tobacco may have certain similarities, but they also have significant 
differences. Methadone is transported in a single dose, reaching a maximum level six 
  
hours after use, which then falls continuously until 24 hours. On the other hand, 
nicotine is delivered in little quantities that reach the central nervous system rapidly 
and undergo rapid clearance in a period of 24 hours (Hiltunen et al., 1995). Moreover, 
oral methadone produces sedative effects, but nicotine acts as a stimulant; these 
antagonist actions may induce tobacco users to use tobacco as stimulant with the aim 
of counteracting the sedative properties from oral methadone by titrating nicotine 
levels as a response to increases in methadone doses and the day-to-day highest serum 
levels of methadone (Preston, 1996). Equally, the stimulating properties of tobacco 
may be neutralised by oral methadone (Richter & Ahluwalia, 2000). This should be 
considered in daily clinical practice when prescribing methadone, as it can be seen 
empirically in many cases that many methadone-maintained individuals increase 
tobacco consumption following commencement and increase of dosage during 
titration, and their tobacco use also drops when they are detoxified in the community.  
 
All the information explained above generates a greater understanding of the issues 
involved when delivering tobacco cessation interventions to methadone-maintained 
individuals and may serve the purpose of delivering brief, on-site interventions that 
will hopefully aid in the goal of decreasing tobacco-related mortality, decreasing 
coexisting drug use and increasing the health outcomes of methadone-maintained 
individuals. 
 
 
The prevalence of cocaine use found in this study, at 11%, is higher than that found in 
the general adult population in the England & Wales, which is 2.2% (Home Office, 
2011). This finding was expected, as it has been recorded that higher rates of cocaine 
  
use in methadone-maintained individuals is an area of concern (Maremmani et al., 
2007). Despite this, the prevalence of cocaine use in methadone-maintained 
individuals in this study is not as high as reported in other studies conducted amongst 
such individuals. Some have reported values from 51.67% (Hartel et al., 1995) to 73% 
(Magura et al., 1998). This may be due to the factor explained above, namely that 
adults living in mainly rural communities such as East Kent are expected to 
experience less use of Class A drugs than those living in urban areas. For cocaine 
dependence, a total of 10% of the participants were found to be dependent upon 
cocaine. A very similar percentage of respondents, slightly over 11%, were found to 
be users of cocaine. This indicates that around 90% of cocaine users are also 
dependent upon cocaine, with about 10% not dependent.  
 
It has been stated that the percentage of alcohol use in the UK general population is 
higher, with an estimated prevalence of 85% (Robinson & Harris, 2009). This study 
identified that 42.01% of respondents were found to be current users of alcohol; this is 
in line with published data from studies reporting 52% (Best et al., 1998)  prevalence 
of alcohol consumption in methadone-maintained individuals. It has been reported 
that the prevalence of hazardous drinking (identified using the AUDIT) in the general 
population in England was 24.2% (McManus, Meltzer H, Brugha, Bebbington P, & 
Jenkins, 2009). In comparison, the present study indicated that 14.2% of participants 
had AUDIT PC scores of 5 or above, indicating hazardous drinking; the remaining 
85% of participants fell under the category of lower risk drinking. A study by 
Senbanjo et al. (2006) found a prevalence of 28.4% for hazardous drinking in a 
sample of methadone-maintained individuals (Senbanjo et al., 2007). The 2007 
General Household Survey used the SADQ-C to identify the prevalence of alcohol 
  
dependence in the general population in England, reporting a prevalence of alcohol 
dependence of 5.9%. Most recorded dependence was categorised as mild (5.55%), 
with relatively few adults reporting symptoms of moderate or severe dependence 
(0.4% and 0.1%, respectively) (McManus et al., 2009). In comparison, the present 
study found that the vast majority of patients have no dependence upon alcohol 
(93.49%), while no respondents were found to have mild dependence, only 2.37% of 
participants were moderately dependent upon alcohol, and 3.55% had severe 
dependence. Only a single respondent (0.59%) was found to have very severe 
dependence; the latter finding was in line with the published evidence. 
 
When compared with the general population, a significant percentage of KCA 
methadone-maintained patients do not drink. There are few factors that can contribute 
to the decreased prevalence of alcohol use amongst methadone-maintained 
individuals at KCA.  
 
In the general population, a significant fraction of opioid-dependent patients state that 
they do not drink, as they do not like the effects of alcohol. Another significant 
proportion might have had alcohol problems in the past and have moved over to 
opioids in an attempt to avoid the problems associated with excessive drinking 
(substitution of addiction). Also, those who are Hepatitis C positive may be abstaining 
from alcohol in line with KCA guidance, which emphasizes abstinence to avoid 
progression to liver disease.  Regular monitoring of breath alcohol concentration 
before methadone is dispensed can serve as a deterrent for problematic alcohol use. 
Also, some relapsing heroin users have reported that Naltrexone Hydrochloride, 
previously prescribed to prevent relapse, contributed to the decrease of alcohol 
  
cravings and further alcohol use. An integral package of care for methadone-
maintained individuals, including consistent brief interventions for alcohol use, 
regular counselling sessions, and harm reduction and day programmes activities may 
have contributed to the decreased prevalence of alcohol use at KCA. Other factors 
may be that heroin is “the drug of choice” in the group of methadone-maintained 
individuals, and another important factor may be that some individuals maintained on 
methadone underreport their alcohol use for fear of putting their methadone 
prescription at risk. Despite the fact that alcohol-dependent patients contribute in a 
minor number to the overall amount of alcohol users, the fact that many of them 
complete alcohol detoxification before entering methadone-maintenance treatment 
may also contribute to the overall decreased number of current alcohol use amongst 
methadone-maintained individuals. This might be an interesting subject to 
investigate in a questionnaire-based study. 
 
 
Limitations 
The participants were not aware of the study hypothesis. Thus, it is rather unlikely 
that the results were influenced by selection bias. Individuals’ self-completed 
questionnaires were anonymised so that the respondents could not be identified; 
therefore, the possibility of information bias was greatly minimised, since it is not 
uncommon for patients to underreport poor health status, illicit drug use or alcohol 
use if they perceive that such a disclosure may have negative consequences for their 
treatment. The results may have been affected by information bias, since some 
individuals may have underreported the number of units of alcohol consumed on the 
AUDIT PC questionnaire as a result of misinterpreting ‘a drink’ as meaning a pint, a 
  
can or a bottle of alcohol. However, this was taken into account, and clear instructions 
were printed on the questionnaires. Still, it has been reported that carefully collected 
self-reports of illicit drugs and alcohol can be as precise and may sometimes be more 
truthful than information obtained by other methods (Babor & Higgins-Biddle, 2000). 
Recall bias, on the other hand, may have not influenced the results, since this study 
investigated the self-reported data of current co-existent use of substances. The 
advantages of the present study, such as flexibility and cost effectiveness, may 
outweigh the above mentioned disadvantages. 
 
 
Conclusions 
The data presented indicate that a significant number of methadone-maintained 
individuals have coexisting substance-use disorders. The assessment of coexistent 
substance-misuse disorders in this group of individuals may be improved with the 
systematic use of screening tools such as SDS, AUDIT PC and SADQ-C. The 
prevalence of coexistent substance-use disorders amongst methadone-maintained 
individuals is higher than for individuals from the general population; despite this, the 
co-existence of some class A substances in individuals who are prescribed methadone 
in rural areas may be inferior to those prescribed methadone in the general population. 
The lower levels of alcohol use amongst methadone-maintained patients found in this 
study (as opposed to the individuals in the general population) also merit further 
investigation. While a specialist methadone prescribing service may not be focused on 
addressing those issues, they need to understand that addiction can be a result of a 
variety of biopsychosocial factors; therefore, the improvement of health outcomes 
resultant upon adequate treatment of coexisting substance-use disorders may 
  
dramatically increase not only the treatment outcomes, but most importantly, the 
quality of life amongst this group of vulnerable individuals. A positive relationship 
between smoking cessation (within one year of entering treatment) and long-term 
outcomes has been established (Tsoh, Chi, Mertens, & Weisner, 2011). Thus, the 
optimisation of pre-existing resources (counselling intended for stimulant and tobacco 
users, brief alcohol interventions and contingency management for alcohol, plus 
partnership with other agencies and General Practitioners) is necessary to address the 
complex issues that interrelate and affect the quality of life amongst patients receiving 
methadone-maintenance treatment. 
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